Cite

HARVARD Citation

    Catlett, I. et al. (n.d.). SAT0226 A first-in-human, study of BMS-986165, a selective, potent, allosteric small molecule inhibitor of tyrosine kinase 2. Annals of the rheumatic diseases. p. 859. [Online]. 
  
Back to record